Auriculo-Nerve Stimulation on Post-Operative Opioid Requirement
NCT05506878
Abdominal Pain, Agnosia
Pittsburgh, Pennsylvania, United States
View Trial DetailsNCT Number: NCT04945135
RBC requirement ein DBD and DCD liver transplants
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain
Background: Controlled donation after cardiac circulatory death (cDCD) is accepted to expand the donor pool for liver transplantation (LT). However, transfusion requirements and perioperative outcomes should be elucidated. The aims of this multicentre study are to assess the red blood cell (RBC) transfusions, one-year graft and patient survival after LT with cDCD compared to donors after brain dead (DBD).
Methods: 591 LT patients conducted in ten centers during 2019 were reviewed. Thromboelastometry was used to manage coagulation and blood product transfusion in all centres. Normothermic regional perfusion was the standard technique for organ recovery.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: intraoperative
Hospital Clinic of Barcelona
Other
Controlled Donors After Circulatory Death and Brain Death: a Multicenter Study of
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05506878
Abdominal Pain, Agnosia
Pittsburgh, Pennsylvania, United States
View Trial DetailsNCT07701031
Digestive System Diseases, Fibrosis
Münster, Germany
View Trial DetailsNCT06635564
Bleeding Disorder, Brain Diseases
Vienna, Austria
View Trial DetailsNCT04836923
Cirrhosis, Fibrosis
Chicago, Illinois, United States
View Trial Details